Howard Lee

Insider Reports History

Entity
Individual
Location
13 F 2, No. 36, Lane 48, Section 3, Nan Jing East Road, Taipei, Taiwan, China
Signature
/s/ Eva Wen, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Howard Lee:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Amphastar Pharmaceuticals, Inc. Director Common Stock 148K $6.21M $42.04 Jun 5, 2024 Direct
Amphastar Pharmaceuticals, Inc. Director Stock Option (right to buy) 6.86K Jun 3, 2024 Direct

Insider Reports Filed by Howard Lee

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AMPH Amphastar Pharmaceuticals, Inc. Jun 3, 2024 3 -$24.3K 4 Jun 5, 2024 Director
AMPH Amphastar Pharmaceuticals, Inc. Jun 10, 2023 1 -$17.1K 4 Jun 12, 2023 Director
AMPH Amphastar Pharmaceuticals, Inc. Jun 5, 2023 2 $0 4 Jun 7, 2023 Director
AMPH Amphastar Pharmaceuticals, Inc. Jun 1, 2023 3 -$473K 4 Jun 5, 2023 Director
AMPH Amphastar Pharmaceuticals, Inc. Jun 10, 2022 2 $0 4 Jun 14, 2022 Director
AMPH Amphastar Pharmaceuticals, Inc. Jun 6, 2022 3 -$213K 4 Jun 7, 2022 Director
AMPH Amphastar Pharmaceuticals, Inc. May 23, 2022 3 -$178K 4 May 25, 2022 Director
AMPH Amphastar Pharmaceuticals, Inc. Jun 12, 2021 1 -$3.13K 4 Jun 14, 2021 Director
AMPH Amphastar Pharmaceuticals, Inc. Jun 7, 2021 8 -$45.4K 4 Jun 8, 2021 Director
AMPH Amphastar Pharmaceuticals, Inc. May 20, 2021 3 -$33.1K 4 May 24, 2021 Director